Inventor · disambiguated record
Roberto Chiarle
Also filed as: CHIARLE ROBERTO
5 granted patents·3 pending applications·8 citations·filing 2008–2024
71Inventor score
Top patents by PatentIndex Score
8 records- 0182US9650614B2Anaplastic lymphoma kinase (ALK) as oncoantigen for lymphoma vaccinationCHIARLE ROBERTO·Filed 2015·Granted May 16, 2017·3 cites·8 claims
- 0280US8980287B2Anaplastic lymphoma kinase (ALK) as oncoantigen for lymphoma vaccinationCHIARLE ROBERTO·Filed 2008·Granted Mar 17, 2015·3 cites·5 claims
- 0370US9518293B2High throughput genome-wide translocation sequencingALT FREDERICK W·Filed 2012·Granted Dec 13, 2016·2 cites·11 claims
- 0468US2025057930A1Anaplastic lymphoma kinase (alk) cancer vaccines and methods of use thereofCHILDRENS MEDICAL CT CORP·Filed 2024·Application pending·0 cites
- 0553US10508304B2High throughput genome-wide translocation sequencingCHILDRENS MEDICAL CENTER·Filed 2016·Granted Dec 17, 2019·0 cites·13 claims
- 0649US2023101046A1Anaplastic lymphoma kinase chimeric antigen receptors and methods of useCHILDRENS MEDICAL CT CORP·Filed 2021·Application pending·0 cites
- 0748US2023020894A1An anaplastic lymphoma kinase (alk) cancer vaccine and methods of useCHILDRENS MEDICAL CENTER·Filed 2020·Application pending·0 cites
- 0843US11530253B2Customized class switch of immunoglobulin genes in lymphoma and hybridoma by CRISPR/CAS9 technologyCHILDRENS MEDICAL CT CORP·Filed 2017·Granted Dec 20, 2022·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Roberto Chiarle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →